Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | TP53 | P04637 | 4/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.55 |
| ▸ | MAPT | P10636 | 5/20 | 0.55 |
| ▸ | MEN1 | O00255 | 5/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | LMNA | P02545 | 6/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4455855 | 0.92 | TSHR (0.62) | MAPK1TSHRTP53CA1CA2 | |
| SCHEMBL13299337 | 0.92 | KMT2A (0.49) | MAPK1TSHRTP53CA1CA2 | |
| SCHEMBL4021180 | 0.89 | TSHR (0.59) | MAPK1TSHRTP53CA1CA2 | |
| SCHEMBL23066466 | 0.88 | ALDH1A1 (0.61) | MAPK1TSHRTP53CA1CA2 | |
| SCHEMBL12216379 | 0.88 | NPC1 (0.51) | MAPK1TSHRTP53KMT2AMAPT | |
| SCHEMBL15005350 | 0.86 | SIRT5 (0.58) | MAPK1TSHRTP53KMT2AMAPT | |
| SCHEMBL15005603 | 0.84 | NPC1 (0.55) | MAPK1TSHRTP53KMT2AMAPT | |
| SCHEMBL16790688 | 0.83 | ADORA3 (0.46) | MAPK1TSHRTP53CA2KMT2A | |
| SCHEMBL9488528 | 0.83 | MAPK1 (0.58) | MAPK1TSHRKMT2AMAPTMEN1 | |
| SCHEMBL4398788 | 0.82 | TP53 (0.67) | MAPK1TSHRTP53CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170189277-A1 | COMPOSITE PIGMENT AND METHOD FOR PREPARATION THEREOF | L'OREAL (FR) | 2017-07-06 | — | — | US | disclosed |
| US-20170189277-A1 | COMPOSITE PIGMENT AND METHOD FOR PREPARATION THEREOF | L'OREAL (FR) | 2017-07-06 | — | — | US | disclosed |
| US-9669243-B2 | Delivery of hydrophobic benefit agents from bodywashes and the like onto a keratinous substrate | BASF SE (DE) | 2017-06-06 | — | — | US | disclosed |
| US-20150190320-A1 | COSMETIC COMPOSITION COMPRISING COMPOSITE SUNSCREEN PARTICLES | L'OREAL (FR) | 2015-07-09 | — | — | US | disclosed |
| US-20150190320-A1 | COSMETIC COMPOSITION COMPRISING COMPOSITE SUNSCREEN PARTICLES | L'OREAL (FR) | 2015-07-09 | — | — | US | disclosed |
| US-20150157539-A1 | COSMETIC COMPOSITION COMPRISING COMPOSITE PARTICLES | L'OREAL (FR) | 2015-06-11 | — | — | US | disclosed |
| US-20150157539-A1 | COSMETIC COMPOSITION COMPRISING COMPOSITE PARTICLES | L'OREAL (FR) | 2015-06-11 | — | — | US | disclosed |
| US-8882902-B2 | Composite pigment and method for preparation thereof | L'OREAL (FR) | 2014-11-11 | — | — | US | disclosed |
| US-8882902-B2 | Composite pigment and method for preparation thereof | L'OREAL (FR) | 2014-11-11 | — | — | US | disclosed |
| US-20130309285-A1 | COMPOSITE PIGMENT AND METHOD FOR PREPARATION THEREOF | L'OREAL (FR) | 2013-11-21 | — | — | US | disclosed |
| WO-2008122516-A2 | SUNSCREEN AND PERSONAL CARE COMPOSITIONS COMPRISING A SELECT COPOLYMER | BASF SE (CH) | 2008-10-16 | — | — | WO | disclosed |
| WO-2008122517-A2 | SUNSCREEN COMPOSITIONS COMPRISING A RANDOM TERPOLYMER | BASF SE (CH) | 2008-10-16 | — | — | WO | disclosed |
| US-20080247976-A1 | water-resistant cosmetic or dermatological compositions for the UV-photoprotection of human skin and/or hair with enhanced stability to water | DUEVA-KOGANOV OLGA V | 2008-10-09 | — | — | US | disclosed |
| US-20080247975-A1 | Sunscreen and personal care compositions comprising a select copolymer | CIBA CORP. | 2008-10-09 | — | — | US | disclosed |
| US-20080089853-A1 | Amphoteric Ethyl Methacrylate Copolymers and Use Thereof | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-17 | — | — | US | disclosed |
| US-20080019929-A1 | Micro-Particulate Organic Uv Absorber Composition | CIBA SPECIALTY CHEMICALS CORP. | 2008-01-24 | — | — | US | disclosed |
| EP-0658156-B1 | HYDROXYPHENYL-S-TRIAZINES | CIBA SC HOLDING AG (CH) | 2002-10-09 | — | — | EP | disclosed |
| US-5942564-A | OXIDATION AND HEAT RESISTANCE; PHOTOSTABILITY | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-08-24 | — | — | US | disclosed |
| EP-0658156-A1 | HYDROXYPHENYL-S-TRIAZINES | Ciba SC Holding AG (CH) | 1995-06-21 | — | — | EP | disclosed |
| WO-1994005645-A1 | HYDROXYPHENYL-S-TRIAZINES | CIBA-GEIGY AG (CH) | 1994-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080247976-A1 | water-resistant cosmetic or dermatological compositions for the UV-photoprotection of human skin and/or hair with enhanced stability to water | CUTA, POLR1C, MSH6 | MAPK1 3506/4885TSHR 2856/4885TP53 25/4885 |
| US-20080089853-A1 | Amphoteric Ethyl Methacrylate Copolymers and Use Thereof | MEP1A, ACMSD, MEP1B | MAPK1 2568/4885TSHR 4833/4885TP53 1671/4885 |
| US-20170189277-A1 | COMPOSITE PIGMENT AND METHOD FOR PREPARATION THEREOF | TYR, RAB5IF, MITF | MAPK1 3362/4885TSHR 3682/4885TP53 337/4885 |
| US-20080247975-A1 | Sunscreen and personal care compositions comprising a select copolymer | MSH6, CUTA, ERCC5 | MAPK1 3695/4885TSHR 3904/4885TP53 21/4885 |
| US-20150157539-A1 | COSMETIC COMPOSITION COMPRISING COMPOSITE PARTICLES | MITF, RAB5IF, TYR | MAPK1 3119/4885TSHR 1743/4885TP53 640/4885 |
| US-20080019929-A1 | Micro-Particulate Organic Uv Absorber Composition | PCNA, FASN, CCNO | MAPK1 3003/4885TSHR 2450/4885TP53 195/4885 |
| US-20130309285-A1 | COMPOSITE PIGMENT AND METHOD FOR PREPARATION THEREOF | TYR, RAB5IF, MITF | MAPK1 3362/4885TSHR 3682/4885TP53 337/4885 |
| US-20150190320-A1 | COSMETIC COMPOSITION COMPRISING COMPOSITE SUNSCREEN PARTICLES | XPA, ERCC1, ERCC4 | MAPK1 3940/4885TSHR 2451/4885TP53 869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.